Assessment of cytokines, microRNA and patient related outcome measures in conversion disorder/functional neurological disorder (CD/FND): The CANDO clinical feasibility study

der Feltz-Cornelis C van; Sally Brabyn; Jonathan Ratcliff; Danielle Varley; Victoria Allgar; Simon Gilbody; Chris Clarke; Dimitris Lagos

doi:10.1016/j.bbih.2021.100228

Assessment of cytokines, microRNA and patient related outcome measures in conversion disorder/functional neurological disorder (CD/FND): The CANDO clinical feasibility study

der Feltz-Cornelis C van
, Sally Brabyn
, Jonathan Ratcliff
, Danielle Varley
, Victoria Allgar
, Simon Gilbody
, Chris Clarke
, Dimitris Lagos

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

19 Downloads (Pure)

Original language	English
Journal	Brain, Behavior, and Immunity - Health
Volume	13
Early online date	5 Mar 2021
DOIs	https://doi.org/10.1016/j.bbih.2021.100228
Publication status	Published - May 2021

Access to Document

10.1016/j.bbih.2021.100228

1-s2Final published version, 1.14 MB

Cite this

van, D. F.-C. C., Brabyn, S., Ratcliff, J., Varley, D., Allgar, V., Gilbody, S., Clarke, C., & Lagos, D. (2021). Assessment of cytokines, microRNA and patient related outcome measures in conversion disorder/functional neurological disorder (CD/FND): The CANDO clinical feasibility study. Brain, Behavior, and Immunity - Health, 13. https://doi.org/10.1016/j.bbih.2021.100228

@article{75f6b782c7e5496cb93692a6ee0f9aa6,

title = "Assessment of cytokines, microRNA and patient related outcome measures in conversion disorder/functional neurological disorder (CD/FND): The CANDO clinical feasibility study",

author = "van, \{der Feltz-Cornelis C\} and Sally Brabyn and Jonathan Ratcliff and Danielle Varley and Victoria Allgar and Simon Gilbody and Chris Clarke and Dimitris Lagos",

year = "2021",

month = may,

doi = "10.1016/j.bbih.2021.100228",

language = "English",

volume = "13",

journal = "Brain, Behavior, and Immunity - Health",

issn = "2666-3546",

publisher = "Elsevier Inc.",

}

Assessment of cytokines, microRNA and patient related outcome measures in conversion disorder/functional neurological disorder (CD/FND): The CANDO clinical feasibility study. / van, der Feltz-Cornelis C; Brabyn, Sally; Ratcliff, Jonathan et al.
In: Brain, Behavior, and Immunity - Health, Vol. 13, 05.2021.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Assessment of cytokines, microRNA and patient related outcome measures in conversion disorder/functional neurological disorder (CD/FND): The CANDO clinical feasibility study

AU - van, der Feltz-Cornelis C

AU - Brabyn, Sally

AU - Ratcliff, Jonathan

AU - Varley, Danielle

AU - Allgar, Victoria

AU - Gilbody, Simon

AU - Clarke, Chris

AU - Lagos, Dimitris

PY - 2021/5

Y1 - 2021/5

UR - https://pearl.plymouth.ac.uk/pms-research/1021/

U2 - 10.1016/j.bbih.2021.100228

DO - 10.1016/j.bbih.2021.100228

M3 - Article

SN - 2666-3546

VL - 13

JO - Brain, Behavior, and Immunity - Health

JF - Brain, Behavior, and Immunity - Health

ER -

Assessment of cytokines, microRNA and patient related outcome measures in conversion disorder/functional neurological disorder (CD/FND): The CANDO clinical feasibility study

Access to Document

Other files and links

Cite this